<PAGE> 1
ANTHRA PHARMACEUTICALS, INC.
103 Carnegie Center, Suite 102
Princeton, NJ 08540
(609) 514-1060
January 18, 1999
VIA EDGAR
Division of Corporation Finance
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Attention: Filing Desk
Re: Anthra Pharmaceuticals, Inc. Registration Statement on Form
8-A File Numbers 000-24107 and 001-14639 Request for
Withdrawal
Ladies and Gentlemen:
Anthra Pharmaceuticals, Inc., a Delaware corporation (the
"Registrant"), hereby makes application to immediately withdraw its Registration
Statement on Form 8-A (the "8-A Registration Statement"), relating to the
Registrant's securities. The Registrant filed the 8-A Registration Statement on
November 24, 1998, under Section 12(b) (File No. 001-14639) and Section 12(g)
(File No. 000-24107) of the Securities Exchange Act of 1934, as amended (the
"'34 Act"). This request for withdrawal of the 8-A Registration Statement is
being made because the Registrant will not request effectiveness for its
Registration Statement on Form S-1 (Registration No. 333-47725) by the date the
8-A Registration Statement would automatically become effective pursuant to
Section 12 of the '34 Act.
Should you have any questions regarding this matter, please call our
attorney, Joseph V. Cuomo of Morrison & Foerster LLP, at (212) 468-8177.
Sincerely,
ANTHRA PHARMACEUTICALS, INC.
By: /s/ Karen Krumeich
------------------------------------
Karen Krumeich
Chief Financial Officer
cc: Heather Maples
Securities and Exchange Commission
Kelly Caralis
Boston Stock Exchange
Sonja D. Caison
The Nasdaq Stock Market, Inc.
